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General information
All chemicals were used as received unless otherwise noted. Methylene chloride (CH 2 Cl 2 )
was passed through alumina under nitrogen prior to use. Anhydrous, amine free dimethylformamide (DMF) was purchased from Alfa Aesar. Analytical reverse-phase HPLC was performed on an Agilent 1200 equipped with an Aeris PEPTIDE 2.6u XB-C18 column (Phenomonex). Semipreparative reverse-phase HPLC was performed on a Beckman Gold Series P equipped with a Zorbax SB-C18 column (Agilent). HPLC grade acetonitrile and 18 MΩ H 2 O, each containing 0.1% trifluoroacetic acid (TFA), were used for analytical and semi-preparative reverse-phase HPLC. All peptides were prepared and used as the trifluoroacetate salts, and were assumed to have one trifluoroacetic acid per ammonium group on each peptide. 
Synthesis of peptides
S12
We did not screen crystallization conditions for peptide 2, as it afforded crystals suitable for X-ray diffraction in the same conditions, and with the same peptide concentration (10 mg/mL 18 MΩ water) as peptide 4. Peptide 2 forms a cloudy suspension when a 10 mg/mL solution in 18 MΩ water is prepared. To better solvate peptide 2 for crystallographic experiments we sonicated the 10 mg/mL solution for ~2 h until it was less cloudy.
We optimized crystallization conditions for peptides 2 and 4 using a 4x6 matrix Hampton VDX 24-well plate. We varied the HEPES buffer pH in each row in increments of 0.5 pH units Three hanging-drops were prepared per borosilicate glass slide by combining a solution of peptides 2 or 4 (1 μL, 10 mg/mL) and the well solution (1 μL) in a ratio of 1:1, 2:1, and 1:2.
Slides were inverted and pressed firmly against the silicone grease surrounding each well.
Crystals of peptides 2 and 4 grew in ~72 h. Crystallization conditions were further optimized using smaller variations in HEPES buffer pH (in increments of 0.25 pH units) and Jeffamine M-S13 a copper or steel pin and flash frozen in liquid nitrogen prior to data collection. The optimized crystallization conditions for peptides 2 and 4 are summarized in Table S1 .
X-ray crystallographic data collection, data processing, and structure determination for peptides 2 and 4.
Diffraction data for peptides 2 and 4 were collected on a Rigaku Micromax-007HF X-ray diffractometer with a rotating copper anode at 1.54 Å wavelength with 0.5° oscillation.
Diffraction data were collected using CrystalClear. Diffraction data were scaled and merged using XDS. 4 Coordinates for the anomalous signals were determined by HySS in the Phenix software suite 1.10.1. 4 Electron density maps were generated using anomalous coordinates determined by HySS as initial positions in Autosol. Molecular manipulations of the models were performed with Coot. Coordinates were refined with phenix.refine.
Diffraction data for peptide 2 were also collected at Lawrence Berkeley National Laboratory (Berkeley, California) on synchrotron beamline 8.2.1 at 1.00 Å wavelength with 0.5° oscillation and a detector distance of 220 mm. 3 Diffraction data were scaled and merged using XDS. 4 Electron density maps were generated by isomorphous replacement of coordinates from peptide 4 using Phaser in software suite Phenix 1.10.1. 5 Molecular manipulations of the models were performed with Coot. 6 Coordinates were refined with phenix.refine.
Dot blot analysis of peptide 2.
A 10 mg/mL (3.85 mM) stock solution of peptide 2 was prepared gravimetrically by West Femto Maximum Sensitivity Substrate, product# 34095) was prepared according to manufacture's protocol and poured onto the membrane. The membrane was allowed to incubate in the chemiluminescence substrate for ~10 min before imaging. The blot was imaged using a standard SLR camera. 
